An international, multicenter, survey-based analysis of practice and management of acute liver failure.


Journal

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
ISSN: 1527-6473
Titre abrégé: Liver Transpl
Pays: United States
ID NLM: 100909185

Informations de publication

Date de publication:
23 May 2024
Historique:
received: 23 02 2024
accepted: 02 05 2024
medline: 22 5 2024
pubmed: 22 5 2024
entrez: 22 5 2024
Statut: aheadofprint

Résumé

Acute liver failure (ALF) is an acute liver dysfunction with coagulopathy and hepatic encephalopathy in a patient with no known liver disease. As ALF is rare and large clinical trials are lacking, the level of evidence regarding its management is low-moderate, favoring heterogeneous clinical practice. In this international multicenter survey study, we aimed to investigate the current practice and management of patients with ALF. An online survey targeting physicians who care for patients with ALF was developed by the International Liver Transplantation Society ALF Special-Interest Group. The survey focused on management and liver transplantation (LT) practices of ALF. Survey questions were summarized overall and by geographic region. A total of 267 physicians completed the survey with a survey response rate of 21.36%. Centers from all continents were represented. More than 90% of physicians were specialized in either transplant hepatology/surgery or anesthesiology/critical care. Two hundred and fifty-two (94.4%) respondents' institutions offered LT. A total of 76.8% of respondents' centers had a dedicated liver- or transplant- intensive care unit (p<0.001). Median time to LT was within 48 hours in 12.7% of respondents' centers, 72 hours in 35.6%, one week in 37.6%, and more than one week in 9.6% (p<0.001). Deceased-donor liver graft (49.6%) was the most common type of graft offered. For consideration of LT, 84.8% of physicians used King's College Criteria and 41.6% used Clichy Criteria. Significant differences were observed between Asia, Europe, and North America for offering LT, number of LTs performed, volume of ALF patients, admission to a dedicated intensive care unit, median time to LT, type of liver graft, monitoring hepatic encephalopathy and intracranial pressure, management of coagulopathy, and utilization of different criteria for LT. In our study, we observed significant geographic differences in the practice and management of ALF. As ALF is rare multicenter studies are valuable to identify global practice.

Identifiants

pubmed: 38775498
doi: 10.1097/LVT.0000000000000402
pii: 01445473-990000000-00387
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American Association for the Study of Liver Diseases.

Auteurs

Ahmet Gurakar (A)

Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Isabel Conde Amiel (I)

Hepatology and Liver Transplantation Unit, Hospital Universitario y Politécnico La Fe, IIS La Fe, Valencia. Ciberehd, Instituto de Salud Carlos III, Madrid, Spain.

N Begum Ozturk (NB)

Department of Internal Medicine, Beaumont Hospital, Royal Oak, MI, USA.

Florent Artru (F)

Liver Department, Rennes University Hospital, University of Rennes, Inserm U1241 NuMeCan, France.

Nazia Selzner (N)

Multi-Organ Transplant Program, University Health Network, University of Toronto, Toronto, ON, Canada.

Kevin J Psoter (KJ)

Division of General Pediatrics, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Joanna C Dionne (JC)

Divisions of Gastroenterology/Critical Care Medicine, Department of Medicine, Department of Health Research Medicine, Evidence and Impact, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Canada.

Constantine Karvellas (C)

Divisions of Hepatology and Critical Care Medicine, University of Alberta, Edmonton, Canada.

Akila Rajakumar (A)

The Institute of Liver Disease & Transplantation, Dr. Rela Institute & Medical Centre, Bharath Institute of Higher Education & Research, Chennai, India.

Fuat Saner (F)

Organ Transplant Center of Excellence, King Faisal Specialized Hospital & Research Center, Riyadh Saudi Arabia.
Department of General, Visceral and Transplantation Surgery, University of Duisburg-Essen, 45147, Essen, Germany.

Ram M Subramanian (RM)

Liver Transplantation & Liver Critical Care Services, Emory University, Atlanta, GA, USA.

Li-Ying Sun (LY)

Critical Liver Diseases & Liver Transplantation Center, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Anil Dhawan (A)

Department of Pediatrics and Pediatric Liver GI and Nutrition Center and Mowat Labs, King's College Hospital, London, UK.

Audrey Coilly (A)

Paul-Brousse Hospital, Public Hospitals of Paris, 12 Avenue Paul Vaillant Couturier, FHU Hépatinov, Villejuif, France.

Classifications MeSH